Association between Atherogenic Dyslipidemia and Subclinical Myocardial Injury in the General Population

Association between Atherogenic Dyslipidemia and Subclinical Myocardial Injury in the General Population

Subclinical myocardial injury (SCMI) is associated with an increased risk of poor cardiovascular disease (CVD) outcomes. Understanding the underlying risk factors for SCMI is crucial for the prevention and management of CVD. We hypothesized that atherogenic dyslipidemia, a combination of high trigly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2024-08, Vol.13 (16), p.4946
Hauptverfasser: Elbadawi, Nada S, Sobih, Moaze H, Soliman, Mai Z, Mostafa, Mohamed A, Kazibwe, Richard, Soliman, Elsayed Z
Format: Artikel
Sprache:eng
Schlagworte:
Atherosclerosis
Body mass index
Cardiovascular disease
Cholesterol
Complications and side effects
Demographics
Diabetes
Diagnosis
Dyslipidemias
Electrocardiography
Exercise
Glucose
High density lipoprotein
Hypertension
Lipids
Metabolic disorders
Metabolic syndrome
Obesity
Oxidation
Regression analysis
Risk factors
Womens health
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Subclinical myocardial injury (SCMI) is associated with an increased risk of poor cardiovascular disease (CVD) outcomes. Understanding the underlying risk factors for SCMI is crucial for the prevention and management of CVD. We hypothesized that atherogenic dyslipidemia, a combination of high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C), is associated with an increased risk of SCMI. : This analysis from the third National Health and Nutrition Examination Survey (NHANES-III) included 7093 participants (age 59.3 ± 13.4 years, 52.8% women, and 49.4% White) free of CVD. Atherogenic dyslipidemia was defined as TG ≥ 150 mg/dL and HDL-C < 40 mg/dL in men or
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm13164946